Illness	Number of cases
Left ventricular failure unspecified (I50.14)	189
Unspecified acute lower respiratory infection (J22)	119
Essential primary hypertension (I10.01)	69
Syncope and collapse (R55)	66
Pneumonia organism unspecified - Bronchopneumonia unspecified organism (J18.0)	44
Atrial fibrillation and flutter - Paroxysmal atrial fibrillation (I48.0)	42
Acute kidney failure unspecified (N17.99)	38
Urticaria - Allergic urticaria (L50.0)	35
Volume depletion (E86)	34
Acute myocardial infarction - Non-ST elevation NSTEMI myocardial infarction (I21.4)	34

Top 10 treatments

Treatment	Number
Computed tomography (CT) of the head without contrast medium (3-200)	395
Intensive care monitoring of respiration, the heart and the circulation without measurement of the pressure in the pulmonary artery and in the right atrium of the heart (8-930)	339
(9-984.7)	268
(9-984.8)	268
Computed tomography of the chest with contrast medium (3-222)	202
Examination of the oesophagus, stomach and duodenum by endoscopy (1-632.0)	192
Function-orientated physical exercises and uses (8-561.1)	186
Injection or administration of medicines into the urinary bladder (8-132.x)	180
(9-984.9)	137
Computed tomography of the abdomen with contrast medium (3-225)	117

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 0100

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0
Bezeichnung
Teilnahme externe Qualitätssicherung	0

Quality of participation in the Disease Management Programme (DMP)
No participation

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)
No participation

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
13	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
9	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
7	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility